36275100|t|Melamine-derived N-rich C-entrapped Au nanoparticles for sensitive and selective monitoring of dopamine in blood samples.
36275100|a|Several neurological disorders, including Parkinson's disease, schizophrenia, human immunodeficiency virus infection, and restless leg syndrome, majorly result from disruption in the dopamine (DA) level. Thus, useful information about the treatment and prevention of various genetic majorly mental health problems can be obtained through precise and real-time monitoring of DA. Herein, we report the fabrication of novel N-rich carbon-coated Au nanoparticles (NC@Au-NPs) by deriving from melamine-crosslinked citrate-stabilized Au NPs. NC@Au-NPs offer fast electro-oxidation efficacy towards DA, because of strong electrostatic attraction between negatively charged NC@Au-NPs and positively charged DA. The catalytic efficacy and shelf life of the designed system were further boosted by applying a mixture of polydopamine (PDA) and benzimidazolium-1-acetate ionic liquid (IL) as a sandwich between the working electrode surface (graphitic pencil electrode: GPE) and the designed nanohybrid NC@Au-NPs as a redox mediator. The results indicate that the designed novel NC@Au/PDA-IL/GPE exhibits excellent sensitivity, selectivity, and reproducibility over a wide linear range (50-1000 nm) and a low detection limit of 0.002 muM +- 0.001 as well. The developed sensor was successfully applied to monitor DA in the blood of COVID-19 quarantined patients and pharmaceutical samples with high accuracy, thus suggesting a powerful tool for the diagnosis of mental problems.
36275100	0	8	Melamine	Chemical	MESH:C011907
36275100	24	25	C	Chemical	MESH:D002244
36275100	36	38	Au	Chemical	MESH:D006046
36275100	95	103	dopamine	Chemical	MESH:D004298
36275100	130	152	neurological disorders	Disease	MESH:D009461
36275100	164	183	Parkinson's disease	Disease	MESH:D010300
36275100	185	198	schizophrenia	Disease	MESH:D012559
36275100	200	238	human immunodeficiency virus infection	Disease	MESH:D015658
36275100	244	265	restless leg syndrome	Disease	MESH:D012148
36275100	305	313	dopamine	Chemical	MESH:D004298
36275100	315	317	DA	Chemical	MESH:D004298
36275100	413	435	mental health problems	Disease	MESH:D000076082
36275100	496	498	DA	Chemical	MESH:D004298
36275100	550	556	carbon	Chemical	MESH:D002244
36275100	564	566	Au	Chemical	MESH:D006046
36275100	582	587	NC@Au	Chemical	-
36275100	610	618	melamine	Chemical	MESH:C011907
36275100	631	638	citrate	Chemical	MESH:D019343
36275100	650	652	Au	Chemical	MESH:D006046
36275100	658	664	NC@Au-	Chemical	-
36275100	714	716	DA	Chemical	MESH:D004298
36275100	788	794	NC@Au-	Chemical	-
36275100	821	823	DA	Chemical	MESH:D004298
36275100	932	944	polydopamine	Chemical	MESH:C568283
36275100	946	949	PDA	Chemical	MESH:C568283
36275100	955	993	benzimidazolium-1-acetate ionic liquid	Chemical	-
36275100	1080	1083	GPE	Chemical	MESH:C062053
36275100	1113	1118	NC@Au	Chemical	-
36275100	1118	1122	-NPs	Chemical	MESH:D009405
36275100	1189	1194	NC@Au	Chemical	-
36275100	1195	1201	PDA-IL	Chemical	-
36275100	1202	1205	GPE	Chemical	MESH:C062053
36275100	1423	1425	DA	Chemical	MESH:D004298
36275100	1442	1450	COVID-19	Disease	MESH:D000086382
36275100	1463	1471	patients	Species	9606
36275100	1572	1587	mental problems	Disease	MESH:D008607
36275100	Association	MESH:C011907	MESH:D004298
36275100	Association	MESH:D004298	MESH:D010300
36275100	Association	MESH:C011907	MESH:D006046
36275100	Association	MESH:D004298	MESH:D012559
36275100	Association	MESH:D002244	MESH:D006046
36275100	Association	MESH:D004298	MESH:D009461
36275100	Association	MESH:D004298	MESH:D000076082
36275100	Association	MESH:D004298	MESH:D008607
36275100	Association	MESH:D004298	MESH:D012148
36275100	Association	MESH:D004298	MESH:D006046
36275100	Association	MESH:D004298	MESH:D000086382
36275100	Association	MESH:D002244	MESH:D004298
36275100	Association	MESH:D004298	MESH:D015658
36275100	Association	MESH:D006046	MESH:D019343

